|
|
||||||||
Journal of Lipid Research, Vol 37, 1189-1197, Copyright © 1996 by Lipid Research, Inc.
T Mikami, A Ohshima, EH Mosbach, BI Cohen, N Ayyad, M Yoshii, K Ohtani, K Kihira, CD Schteingart and T Hoshita
The metabolism of 3 alpha,7 alpha-dihydroxy-25,26-bishomo-5 beta-
cholane-26-sulfonate (bishomoCDC-sul), the sulfonate analogue of
bishomochenodeoxycholic acid, and its effect on biliary bile acid
composition were studied during chronic administration in the hamster.
After oral administration of radiolabeled bishomoCDC-sul, more than 80% of
the radioactivity was excreted into the feces within 7 days, both as the
unchanged sulfonate (38.5%) and two more polar metabolites (50.0% and
11.5%). The half time of the fecal excretion was 1.6 days. In gallbladder
bile, the unchanged sulfonate and its major metabolite accounted for 19.1%
and 19.8% of total bile acids, respectively. In another experiment,
hamsters were fed bishomoCDC-sul with antibiotics to evaluate the site of
biotransformation. Even when the number of intestinal microorganisms was
greatly reduced, the same three metabolites were found in the feces:
bishomoCDC-sul (44.0%) and the two polar metabolites (30.8% and 25.1%). The
major metabolite was isolated from feces of the hamsters fed bishomoCDC-sul
without antibiotics. Its chemical structure was identified by mass
spectrometry and nuclear magnetic resonance spectroscopy as the 15
alpha-hydroxylated derivative, namely sodium 3 alpha,7 alpha,15
alpha-trihydroxy-25,26- bishomo-5 beta-cholane-26-sulfonate. These results
indicate that after oral administration, the sulfonate analogue of
bishomochenodeoxycholic acid underwent enterohepatic circulation like a
natural bile acid and was transformed, in part, into the 15
alpha-hydroxylated derivative and another more polar metabolite in the
liver of hamsters. There was no evidence that bishomoCDC-sul was
dehydroxylated to a lithocholic acid analogue during enterohepatic cycling.
ARTICLES
15 alpha-hydroxylation of a bile acid analogue, sodium 3 alpha,7 alpha- dihydroxy-25,26-bishomo-5 beta-cholane-26-sulfonate in the hamster
Department of Surgery, Beth Israel Medical Center, New York, NY 10003, USA.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
G. Kakiyama, H. Tamegai, T. Iida, K. Mitamura, S. Ikegawa, T. Goto, N. Mano, J. Goto, P. Holz, L. R. Hagey, et al. Isolation and chemical synthesis of a major, novel biliary bile acid in the common wombat (Vombatus ursinus): 15{alpha}-hydroxylithocholic acid J. Lipid Res., December 1, 2007; 48(12): 2682 - 2692. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kakiyama, T. Iida, T. Goto, N. Mano, J. Goto, T. Nambara, L. R. Hagey, C. D. Schteingart, and A. F. Hofmann Identification of a novel bile acid in swans, tree ducks, and geese: 3{alpha},7{alpha},15{alpha}-trihydroxy-5{beta}-cholan-24-oic acid J. Lipid Res., July 1, 2006; 47(7): 1551 - 1558. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |